Mechanism of human Hb switching: a possible role of the kit receptor/miR 221-222 complex
- PMID: 20305142
- PMCID: PMC2913072
- DOI: 10.3324/haematol.2009.018259
Mechanism of human Hb switching: a possible role of the kit receptor/miR 221-222 complex
Abstract
Background: The human hemoglobin switch (HbF-->HbA) takes place in the peri/post-natal period. In adult life, however, the residual HbF (<1%) may be partially reactivated by chemical inducers and/or cytokines such as the kit ligand (KL). MicroRNAs (miRs) play a pivotal role in normal hematopoiesis: downmodulation of miR-221/222 stimulates human erythropoietic proliferation through upmodulation of the kit receptor.
Design and methods: We have explored the possible role of kit/KL in perinatal Hb switching by evaluating: i) the expression levels of both kit and kit ligand on CD34(+) cells and in plasma isolated from pre-, mid- and full-term cord blood samples; ii) the reactivation of HbF synthesis in KL-treated unilineage erythroid cell cultures; iii) the functional role of miR-221/222 in HbF production.
Results: In perinatal life, kit expression showed a gradual decline directly correlated to the decrease of HbF (from 80-90% to <30%). Moreover, in full-term cord blood erythroid cultures, kit ligand induced a marked increase of HbF (up to 80%) specifically abrogated by addition of the kit inhibitor imatinib, thus reversing the Hb switch. MiR-221/222 expression exhibited rising levels during peri/post-natal development. In functional studies, overexpression of these miRs in cord blood progenitors caused a remarkable decrease in kit expression, erythroblast proliferation and HbF content, whereas their suppression induced opposite effects.
Conclusions: Our studies indicate that human perinatal Hb switching is under control of the kit receptor/miR 221-222 complex. We do not exclude, however, that other mechanisms (i.e. glucocorticoids and the HbF inhibitor BCL11A) may also contribute to the peri/post-natal Hb switch.
Figures
Similar articles
-
MicroRNA-486-3p regulates γ-globin expression in human erythroid cells by directly modulating BCL11A.PLoS One. 2013 Apr 4;8(4):e60436. doi: 10.1371/journal.pone.0060436. Print 2013. PLoS One. 2013. PMID: 23593217 Free PMC article.
-
HbF reactivation in sibling BFU-E colonies: synergistic interaction of kit ligand with low-dose dexamethasone.Blood. 2003 Apr 1;101(7):2826-32. doi: 10.1182/blood-2002-05-1477. Epub 2002 Nov 7. Blood. 2003. PMID: 12424200
-
Hemoglobin switching in unicellular erythroid culture of sibling erythroid burst-forming units: kit ligand induces a dose-dependent fetal hemoglobin reactivation potentiated by sodium butyrate.Blood. 2000 Jun 1;95(11):3555-61. Blood. 2000. PMID: 10828043
-
Unicellular-unilineage erythropoietic cultures: molecular analysis of regulatory gene expression at sibling cell level.Blood. 1999 May 15;93(10):3355-68. Blood. 1999. PMID: 10233888
-
Stringently purified human hematopoietic progenitors/stem cells: analysis of cellular/molecular mechanisms underlying early hematopoiesis.Stem Cells. 1993 Sep;11(5):356-70. doi: 10.1002/stem.5530110503. Stem Cells. 1993. PMID: 8241948 Review.
Cited by
-
miRNA Expression Associated with HbF in Saudi Sickle Cell Anemia.Medicina (Kaunas). 2022 Oct 17;58(10):1470. doi: 10.3390/medicina58101470. Medicina (Kaunas). 2022. PMID: 36295630 Free PMC article.
-
The Role of miRNAs as Therapeutic Tools in Sickle Cell Disease.Medicina (Kaunas). 2021 Oct 14;57(10):1106. doi: 10.3390/medicina57101106. Medicina (Kaunas). 2021. PMID: 34684143 Free PMC article. Review.
-
Erythrocyte microRNAs: a tiny magic bullet with great potential for sickle cell disease therapy.Ann Hematol. 2021 Mar;100(3):607-614. doi: 10.1007/s00277-020-04390-y. Epub 2021 Jan 4. Ann Hematol. 2021. PMID: 33398452 Review.
-
Construction and Analysis of a Long Non-Coding RNA (lncRNA)-Associated ceRNA Network in β-Thalassemia and Hereditary Persistence of Fetal Hemoglobin.Med Sci Monit. 2019 Sep 21;25:7079-7086. doi: 10.12659/MSM.915946. Med Sci Monit. 2019. PMID: 31541070 Free PMC article.
-
MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways.Oncotarget. 2018 Jul 3;9(51):29753-29771. doi: 10.18632/oncotarget.25707. eCollection 2018 Jul 3. Oncotarget. 2018. PMID: 30038718 Free PMC article.
References
-
- Stamatoyannopoulos G, Grosveld F. Hemoglobin switching. In: Stamatoyannopoulos G, Majerus PW, Perlmutter RM, editors. The molecular basis of blood disease. Philadelphia, PA: WB Saunders; 2001. pp. 135–182.
-
- Peterson KR. Hemoglobin switching: new insights. Curr Opin Hematol. 2003;10(2):123–9. - PubMed
-
- Peschle C, Migliaccio G, Migliaccio AR, Lettieri F, Russo G, Gianni AM, et al. Erythropoietic differentiation in humans: in vitro studies on erythroid progenitors and Hb synthesis in fetal, newborn and adult life. Exp Hematol. 1980;8 (Suppl 8):153–9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous